New Hope for RET-Positive Cancer Treatments

CosmicTaco · 2024-11-20T22:11:36.152560+05:30

- LUNGevity Foundation and RETpositive announce a groundbreaking research award for RET-positive cancer. - Dr. Justin Drake's team at the University of Minnesota will explore novel protein degraders to combat drug resistance. - This innovative approach aims to leverage the body's natural degradation process to target RET proteins, offering new treatment avenues. Source: [Pr Newswire](https://www.prnewswire.com/news-releases/justin-drake-phd-announced-as-recipient-of-retpositivelungevity-research-award-302310837.html), [Pr Newswire](https://www.prnewswire.com/news-releases/amy-cummings-md-phd-and-romel-somwar-phd-honored-as-recipients-of-the-hamoui-foundationlungevity-clinical-research-award-302310819.html)

LUNGevity Foundation and RETpositive announce a groundbreaking research award for RET-positive cancer.
Dr. Justin Drake's team at the University of Minnesota will explore novel protein degraders to combat drug resistance.
This innovative approach aims to leverage the body's natural degradation process to target RET proteins, offering new treatment avenues.

Source: Pr Newswire, Pr Newswire